中国生物制药（01177.HK）今日盘中大涨5.13%，引发市场关注。该股在早盘交易中表现强劲，延续了近期的上涨势头。
从整体市场来看，港股医药板块今日表现亮眼。除中国生物制药外，信达生物（01801.HK）涨幅接近15%，开拓药业（09939.HK）涨超7%，石药集团（01093.HK）涨超5%。这表明投资者对医药行业的信心正在增强，可能与行业政策、研发进展或市场需求等因素有关。
值得注意的是，中国生物制药近期获得了南向资金的青睐。据报道，6月3日南向资金增持该公司5174.39万股。截至6月3日收盘，港股通共持有中国生物制药246918.79万股，占流通股的13.16%。这一大规模的资金流入可能是推动股价上涨的重要因素之一，反映出机构投资者对公司未来发展前景的看好。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.